Post-approval studies (Phase 4)UnknownNCT03244709
What this trial is testing
Tocilizumab Dose-tapering and Interruption in Patients With Giant Cell Arteritis Achieving the Clinical Remission.
Who this might be right for
Giant Cell Arteritis
Hospital of Prato 15